Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02ZZC
|
|||
| Former ID |
DIB007147
|
|||
| Drug Name |
NN-8630
|
|||
| Synonyms |
NNC-126-0083; Pegylated human growth hormone (growth hormone deficiency), Novo Nordisk; Pegylated long-acting growthhormone (growth hormone deficiency), Novo Nordisk
Click to Show/Hide
|
|||
| Indication | Growth hormone deficiency [ICD-11: 5A61.3] | Phase 2 | [1] | |
| Company |
Novo Nordisk A/S
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00715689) Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.